• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

MGC Pharmaceuticals Signs Major European Cannabis Supply Agreement

October 4, 2017


Today, MGC Pharmaceuticals Ltd. (ASX:MXC) (OTC:MGCLF) announced that the company signed a 5-year medical marijuana supply and distribution agreement with Lenis farmacevtika, a leading European pharmaceutical distribution company. 


Currently distributing drugs for major pharmaceutical companies like Gilead Sciences, Inc. (NASDAQ:GILD) in 8 different European countries, Lenis is large enough to offer MGC Pharmaceuticals the necessary reach to grow and capture market share. 

Under the new agreement, MGC Pharma will be supplying its medical marijuana flower material as well as pharmaceutical products via Lenis to Central and Eastern Europe. The countries that Lenis will be distributing these products to include Latvia, Lithuania, Estonia, Slovenia, Bosnia and Herzegovina, Serbia, Macedonia, Hungary, Romania, Bulgaria and Poland. The two companies intend to jointly market products to territories like Italy, Greece, Croatia and Germany


For more information on the MGC Pharma deal with Lenis, be sure to check out the full update on the ASX site here. For more Australian marijuana stocks, check out our ASX marijuana stock database


Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.